InsidersTradesSigma
Discover the full record of transactions filed by Miller-Rich Nancy, Director. Insider active across 1 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 3 disclosures have been published. The latest transaction was disclosed on 25 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Nancy Miller-Rich is a Board Member at INTERCEPT PHARMACEUTICALS, INC. She brings valuable expertise in the pharmaceutical field, actively participating in the governance and strategy of the company. Her role is crucial in guiding the organization through its research and development initiatives.